- Home
- FLNT vs FGEN Comparison
FLNT vs FGEN Comparison
Compare FLNT & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLNT
- FGEN
- Stock Information
- Founded
- FLNT 2001
- FGEN 1993
- Country
- FLNT United States
- FGEN United States
- Employees
- FLNT N/A
- FGEN N/A
- Industry
- FLNT Advertising
- FGEN Biotechnology: Pharmaceutical Preparations
- Sector
- FLNT Consumer Discretionary
- FGEN Health Care
- Exchange
- FLNT Nasdaq
- FGEN Nasdaq
- Market Cap
- FLNT 39.2M
- FGEN 33.5M
- IPO Year
- FLNT N/A
- FGEN 2014
- Fundamental
- Price
- FLNT $1.87
- FGEN $5.69
- Analyst Decision
- FLNT Hold
- FGEN Strong Buy
- Analyst Count
- FLNT 1
- FGEN 1
- Target Price
- FLNT $3.00
- FGEN $250.00
- AVG Volume (30 Days)
- FLNT 21.6K
- FGEN 49.2K
- Earning Date
- FLNT 08-18-2025
- FGEN 08-05-2025
- Dividend Yield
- FLNT N/A
- FGEN N/A
- EPS Growth
- FLNT N/A
- FGEN N/A
- EPS
- FLNT N/A
- FGEN N/A
- Revenue
- FLNT $243,850,000.00
- FGEN $6,996,000.00
- Revenue This Year
- FLNT N/A
- FGEN N/A
- Revenue Next Year
- FLNT $11.62
- FGEN N/A
- P/E Ratio
- FLNT N/A
- FGEN N/A
- Revenue Growth
- FLNT N/A
- FGEN N/A
- 52 Week Low
- FLNT $1.50
- FGEN $4.50
- 52 Week High
- FLNT $3.83
- FGEN $38.25
- Technical
- Relative Strength Index (RSI)
- FLNT 45.96
- FGEN 28.80
- Support Level
- FLNT $1.78
- FGEN $5.16
- Resistance Level
- FLNT $1.90
- FGEN $8.13
- Average True Range (ATR)
- FLNT 0.09
- FGEN 0.58
- MACD
- FLNT 0.02
- FGEN -0.26
- Stochastic Oscillator
- FLNT 51.85
- FGEN 11.13
About FLNT Fluent Inc.
Fluent Inc is a data-driven digital marketing services company. It performs customer acquisition services by operating digital marketing campaigns, through which it connects its advertiser clients with consumers company is seeking to reach. It delivers data and performance-based marketing executions to its clients, such as consumer brands, direct marketers and agencies across a wide range of industries, including Financial Products & Services, Media & Entertainment, Health & Wellness, Staffing & Recruitment and Retail & Consumer.
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.